AOD-9604 – 5MG

£45.00

AOD-9604 5mg supplied as a lyophilised preparation for laboratory and scientific research applications. Certificate of Analysis (COA) available where applicable.

Availability: In stock

SKU: AOD-9604-5MG Category:

AOD-9604 5mg Overview

AOD-9604 is a synthetic peptide derived from a specific region of the human growth hormone molecule. It corresponds to a modified sequence associated with amino acids 176–191 of the C-terminal region of human growth hormone.

AOD-9604 has been investigated primarily within metabolic and biochemical research, including preclinical studies examining pathways associated with lipid metabolism and energy regulation.

Importantly, AOD-9604 is structurally and functionally distinct from full-length human growth hormone. Research involving one compound should therefore not automatically be applied to the other.

The available evidence includes laboratory, animal and limited human research. Findings from experimental studies should be interpreted within the limitations of the individual study designs and should not be considered evidence of therapeutic effects.

Interlink Peptides supplies AOD-9604 5mg strictly for laboratory and scientific research applications.

Technical Specification

Compound: AOD-9604
Quantity: 1 × 5mg vial
Form: Lyophilised powder
Peptide length: 16 amino-acid residues
CAS Number: 221231-10-3
Molecular weight: Approximately 1,815 Da
Storage: −20 °C in lyophilised form
After reconstitution: Store refrigerated at 2–8 °C
Certificate of Analysis: Available where applicable

Exact analytical specifications should be confirmed using the Certificate of Analysis applicable to the relevant batch.

Research Background

AOD-9604 was developed from the C-terminal region of human growth hormone and has been investigated within metabolic research.

Published experimental studies have examined the compound in relation to lipid-metabolism pathways and energy regulation. Preclinical models form an important part of the available literature, alongside some human research conducted during the compound’s development.

A key consideration when interpreting this research is that AOD-9604 is not full-length human growth hormone. Its substantially smaller peptide structure means findings relating to human growth hormone should not simply be attributed to AOD-9604.

Researchers should also distinguish mechanistic or preclinical findings from demonstrated clinical outcomes. Interlink Peptides makes no claims regarding weight loss, fat loss or other effects in humans.

Interlink Peptides supplies AOD-9604 exclusively as a research material.

Handling & Storage

Store AOD-9604 in its lyophilised form at approximately −20 °C, protected from light and moisture.

Once reconstituted with water, store refrigerated at approximately 2–8 °C.

Allow the sealed vial to reach an appropriate laboratory working temperature before opening to minimise condensation inside the vial.

Avoid unnecessary repeated freeze-thaw cycles. Preparation, solvent selection and experimental handling should be determined according to the receiving laboratory’s own validated procedures.

Quality & Testing

Certificate of Analysis documentation is available where applicable.

Identity, purity and other analytical specifications should be confirmed against documentation associated with the relevant batch.

Explore our full range of research peptides for laboratory and scientific research applications.

Researchers investigating other metabolic research compounds can also view our Tesamorelin product.

Frequently Asked Questions

What is AOD-9604?

AOD-9604 is a synthetic peptide derived from a modified sequence associated with the C-terminal region of human growth hormone.

Is AOD-9604 the same as human growth hormone?

No. AOD-9604 is a much smaller peptide derived from a particular region of the human growth hormone molecule and should not be considered equivalent to full-length human growth hormone.

What areas of research involve AOD-9604?

Published research has investigated AOD-9604 primarily within metabolic research, including experimental work involving lipid-metabolism and energy-regulation pathways.

What form is AOD-9604 supplied in?

This product is supplied as a lyophilised preparation in a sealed vial containing 5mg of AOD-9604.

Is a Certificate of Analysis available?

Certificate of Analysis documentation is available where applicable. Exact analytical specifications should be checked against documentation relating to the relevant batch.

How should AOD-9604 be stored?

Store the lyophilised product at −20 °C, protected from light and moisture. Once reconstituted with water, store refrigerated at 2–8 °C.

Research Use Only

Interlink Peptides supplies AOD-9604 5mg strictly for in-vitro laboratory and scientific research purposes.

This product is not intended for human or animal consumption, medical treatment, therapeutic use or clinical application.

We do not provide dosing or administration guidance. Purchasers are responsible for ensuring that their intended use complies with applicable laws and institutional requirements.

Weight 0.02 kg
Dimensions 3 × 3 × 5 cm

Reviews

There are no reviews yet.

Be the first to review “AOD-9604 – 5MG”

Your email address will not be published. Required fields are marked *

Shopping Cart
Scroll to Top